Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
3,145
+48
+2% +$3.87K 0.08% 222
2026
Q1
$219K Sell
3,097
-58
-2% -$4.34K 0.07% 245
2025
Q4
$249K Sell
3,155
-125
-4% -$9.89K 0.08% 216
2025
Q3
$270K Sell
3,280
-46
-1% -$3.62K 0.1% 200
2025
Q2
$267K Buy
3,326
+17
+0.5% +$1.31K 0.11% 183
2025
Q1
$266K Sell
3,309
-24
-0.7% -$2K 0.14% 130
2024
Q4
$273K Buy
+3,333
New +$277K 0.14% 136

Other funds holding MET

Sunpointe's MET Position: Q2 2026 in Review

Sunpointe increased its MetLife (MET) stake by 1.5% in Q2 2026, buying an estimated $3.87K and bringing the position to 3,145 shares worth $266K. The position accounts for 0.08% of the portfolio, ranked #222.

Sunpointe first reported a position in MET in Q4 2024 and has held it in 7 quarters since. The position peaked at $273K in Q4 2024. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Sunpointe held 3,145 shares of MetLife worth $266K as of Q2 2026.
  • Sunpointe bought 48 MetLife shares in Q2 2026, an estimated $3.87K.
  • MetLife made up 0.08% of Sunpointe's portfolio in Q2 2026, its #222 holding.
  • Sunpointe first reported a position in MetLife in Q4 2024 and has held it in 7 quarters since.
  • Sunpointe's MetLife position peaked at $273K in Q4 2024.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.